Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax

Post time 2024-2-16 21:58:53

journal：Clinical Cancer Research

Authors：Alexandre Bazinet; Sai Prasad Desikan; Ziyi Li; Juan Jose Rodriguez-Sevilla; Sangeetha Venugopal; Samuel Urrutia; Guillermo Montalban-Bravo; Koji Sasaki; Kelly S. Chien; Danielle Hammond; Rashmi Kanagal-Shamanna; Irene Ganan-Gomez; Tapan M. Kadia; Gautam Borthakur; Courtney D. DiNardo; Naval G. Daver; Elias J. Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero

Published date：--

DOI：10.1158/1078-0432.ccr-23-2860

PDF link：https://aacrjournals.org/clincan ... 886/ccr-23-2860.pdf

Article link：http://dx.doi.org/10.1158/1078-0432.ccr-23-2860

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2024-2-16 21:58:54

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax Copy